Internal medicine (Tokyo, Japan)
Successes and Challenges of Bispecific T-cell Engager Antibodies in the Treatment of Multiple Myeloma.
Ichiro Hanamura, Sivasundaram Karnan, Akinobu Ota, Akiyoshi Takami
Published: 202510.2169/internalmedicine.6617-25
Abstract
Recent advances in drug development have revolutionized the field of oncology, leading to the development of novel therapeutic strategies. Among them, bispecific antibodies (BsAbs) targeting CD3 and tumor antigens have shown significant efficacy in r…
Preview only. Read the full abstract at the source